Immunomodulatory effect of mesenchymal stromal cells: possible mechanisms.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Regenerative medicine

• Publication date

  2008-06-27

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2217/17460751.3.4.531PMID 18588475
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Murine mesenchymal stem cells suppress dendritic cell migration, maturation and antigen presentation.

  2008cited by this paper
• Human Mesenchymal Stem Cells Inhibit Neutrophil Apoptosis: A Model for Neutrophil Preservation in the Bone Marrow Niche

  2008cited by this paper
• Biology of Natural Killer Cells

  2008cited by this paper
• Human Mesenchymal Stem Cells License Adult CD34+ Hemopoietic Progenitor Cells to Differentiate into Regulatory Dendritic Cells through Activation of the Notch Pathway1

  2008cited by this paper
• Human Leukocyte Antigen‐G5 Secretion by Human Mesenchymal Stem Cells Is Required to Suppress T Lymphocyte and Natural Killer Function and to Induce CD4+CD25highFOXP3+ Regulatory T Cells

  2008cited by this paper
• Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study.

  2008cited by this paper
• Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide.

  2008cited by this paper
• Allogeneic mesenchymal stem cell and mesenchymal stem cell-differentiated chondrocyte suppress the responses of type II collagen-reactive T cells in rheumatoid arthritis.

  2008cited by this paper
• Toll‐Like Receptors on Human Mesenchymal Stem Cells Drive Their Migration and Immunomodulating Responses

  2008cited by this paper
• Interferon-gamma does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells.

  2007cited by this paper
• Infusion of allogeneic-related HLA mismatched mesenchymal stem cells for the treatment of incomplete engraftment following autologous haematopoietic stem cell transplantation

  2007cited by this paper
• Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells

  2007cited by this paper
• Concise Review: Mesenchymal Stem Cells: Their Phenotype, Differentiation Capacity, Immunological Features, and Potential for Homing

  2007cited by this paper
• Effects of Human Mesenchymal Stem Cells on the Differentiation of Dendritic Cells from CD34+ Cells

  2007cited by this paper
• Tissue repair using allogeneic mesenchymal stem cells for hemorrhagic cystitis, pneumomediastinum and perforated colon

  2007cited by this paper
• Immunosuppressive Effects of Mesenchymal Stem Cells: Involvement of HLA-G

  2007cited by this paper
• Interferon‐γ does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells

  2007cited by this paper
• Mesenchymal Stem Cells Stimulate Antibody Secretion in Human B Cells

  2007cited by this paper
• No alloantibodies against mesenchymal stromal cells, but presence of anti-fetal calf serum antibodies, after transplantation in allogeneic hematopoietic stem cell recipients

  2007cited by this paper
• Immunosuppressive properties of cloned bone marrow mesenchymal stem cells

  2007cited by this paper
• Adhesion of hematopoietic progenitor cells to human mesenchymal stem cells as a model for cell-cell interaction.

  2007cited by this paper
• Expanded Adipose-Derived Stem Cells Suppress Mixed Lymphocyte Reaction by Secretion of Prostaglandin E2

  2007cited by this paper
• Mesenchymal stem cells inhibit proliferation and apoptosis of tumor cells: impact on in vivo tumor growth

  2007cited by this paper
• Co-Transplantation of HLA-Haploidentical, Bone Marrow Derived Mesenchymal Stem Cells Prevents Graft Failure and Improves Hematological Recovery in T-Cell Depleted Haploidentical Stem Cell Transplantation.

  2007cited by this paper
• Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis.

  2007cited by this paper
• Mesenchymal stem cells fail to trigger effector functions of cytotoxic T lymphocytes

  2007cited by this paper
• Bone marrow mesenchymal stromal cells (BM-MSCs) from healthy donors and auto-immune disease patients reduce the proliferation of autologous- and allogeneic-stimulated lymphocytes in vitro.

  2007cited by this paper
• Mesenchymal Stem Cells Inhibit the Differentiation of Dendritic Cells Through an Interleukin‐6‐Dependent Mechanism

  2007cited by this paper
• Mesenchymal Stem Cells for Treatment of Therapy-Resistant Graft-versus-Host Disease

  2006cited by this paper
• Association of estrogen receptor-alpha genepolymorphisms with venous thrombosis.

  2006cited by this paper
• Human mesenchymal stem cells (hMSCs) expressing truncated soluble vascular endothelial growth factor receptor (tsFlk‐1) following lentiviral‐mediated gene transfer inhibit growth of Burkitt's lymphoma in a murine model

  2006cited by this paper
• Human Mesenchymal Stem Cells Induce T Cell Anergy and Downregulate T Cell Allo-Responses via the TH2 Pathway: Relevance to Tissue Engineering Human Heart Valves

  2006cited by this paper
• Mesenchymal Stem Cells Inhibit Generation and Function of Both CD34+-Derived and Monocyte-Derived Dendritic Cells1

  2006influential reference
• Interactions Between Human Mesenchymal Stem Cells and Natural Killer Cells

  2006cited by this paper
• Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement.

  2006cited by this paper
• Interferon-gamma-stimulated marrow stromal cells: a new type of nonhematopoietic antigen-presenting cell.

  2006cited by this paper
• Human mesenchymal stem cells modulate B-cell functions.

  2006cited by this paper
• Antigen-presenting property of mesenchymal stem cells occurs during a narrow window at low levels of interferon-gamma.

  2006cited by this paper
• Mesenchymal stem cells combined with cyclosporine inhibits cytotoxic T cells.

  2006cited by this paper
• Immunomodulatory Effects of Mesenchymal Stem Cells in a Rat Organ Transplant Model

  2006cited by this paper
• Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation.

  2006cited by this paper
• Prophylaxis against carcinogenesis in three kinds of unestablished tumor models via IL12-gene-engineered MSCs.

  2006cited by this paper
• Mesenchymal stem cells enhance xenochimerism in NK-depleted hosts.

  2006cited by this paper
• Earlier Onset of Syngeneic Tumors in the Presence of Mesenchymal Stem Cells

  2006cited by this paper
• Identification of IL-10 and TGF-beta transcripts involved in the inhibition of T-lymphocyte proliferation during cell contact with human mesenchymal stem cells.

  2006cited by this paper
• Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma

  2006cited by this paper
• Bone Marrow Mesenchymal Stem Cells Suppress Lymphocyte Proliferation In Vitro but Fail to Prevent Graft-versus-Host Disease in Mice1

  2006influential reference
• Autoreactive T cells induce in vitro BM mesenchymal stem cell transdifferentiation to neural stem cells.

  2006cited by this paper
• Mesenchymal stem cells as trophic mediators

  2006cited by this paper
• Adipose Tissue‐Derived Mesenchymal Stem Cells Have In Vivo Immunosuppressive Properties Applicable for the Control of the Graft‐Versus‐Host Disease

  2006cited by this paper
• Human mesenchymal stem cells modulate allogeneic immune cell responses.

  2005cited by this paper
• Allogeneic marrow stromal cells are immune rejected by MHC class I- and class II-mismatched recipient mice.

  2005cited by this paper
• Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells.

  2005cited by this paper
• Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement.

  2005cited by this paper
• Effects of Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells on T and B Lymphocytes from BXSB Mice

  2005cited by this paper
• Gene expression profile of cytokine and growth factor during differentiation of bone marrow-derived mesenchymal stem cell.

  2005cited by this paper
• Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness.

  2005cited by this paper
• Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy.

  2005influential reference
• Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients.

  2005cited by this paper
• T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression.

  2005cited by this paper
• A paradoxical role for IFN-gamma in the immune properties of mesenchymal stem cells during viral challenge.

  2005cited by this paper
• Reversal of the immunosuppressive properties of mesenchymal stem cells by tumor necrosis factor alpha in collagen-induced arthritis.

  2005cited by this paper
• Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway

  2005cited by this paper
• Mesenchymal stem cells induce apoptosis of activated T cells

  2005cited by this paper
• Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells.

  2005cited by this paper
• Interaction between Human NK Cells and Bone Marrow Stromal Cells Induces NK Cell Triggering: Role of NKp30 and NKG2D Receptors1

  2005cited by this paper
• Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms.

  2005cited by this paper
• Human mesenchymal stem cells require monocyte-mediated activation to suppress alloreactive T cells.

  2005cited by this paper
• Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4+ T-cell subsets expressing a regulatory/suppressive phenotype.

  2005cited by this paper
• Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation

  2004influential reference
• Suspended cells from trabecular bone by collagenase digestion become virtually identical to mesenchymal stem cells obtained from marrow aspirates.

  2004cited by this paper
• Dynamic of Distribution of Human Bone Marrow-Derived Mesenchymal Stem Cells After Transplantation into Adult Unconditioned Mice

  2004cited by this paper
• Cotransplantation of Marrow Stromal Cells May Prevent Lethal Graft-versus-Host Disease in Major Histocompatibility Complex Mismatched Murine Hematopoietic Stem Cell Transplantation

  2004cited by this paper
• Cotransplantation of third-party mesenchymal stromal cells can alleviate single-donor predominance and increase engraftment from double cord transplantation.

  2004cited by this paper
• Mesenchymal Stem Cells Inhibit the Expression of CD25 (Interleukin‐2 Receptor) and CD38 on Phytohaemagglutinin‐Activated Lymphocytes

  2004cited by this paper
• Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation.

  2004cited by this paper
• Human mesenchymal stem cells suppress induction of cytotoxic response to alloantigens.

  2004cited by this paper
• Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells.

  2004influential reference
• Effects of Mesenchymal Stem Cells on Differentiation, Maturation, and Function of Human Monocyte-Derived Dendritic Cells

  2004cited by this paper
• Immunologic properties of human fetal mesenchymal stem cells.

  2004cited by this paper
• Characterization and functionality of cell surface molecules on human mesenchymal stem cells.

  2003cited by this paper
• Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates.

  2003cited by this paper
• Mesenchymal stem cells home to injured tissues when co‐infused with hematopoietic cells to treat a radiation‐induced multi‐organ failure syndrome

  2003cited by this paper
• Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells

  2003cited by this paper
• Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals.

  2003influential reference
• HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells.

  2003cited by this paper
• Veto-Like Activity of Mesenchymal Stem Cells: Functional Discrimination Between Cellular Responses to Alloantigens and Recall Antigens1

  2003cited by this paper
• Mesenchymal Stem Cells Inhibit and Stimulate Mixed Lymphocyte Cultures and Mitogenic Responses Independently of the Major Histocompatibility Complex

  2003influential reference
• Unexpected Potential of Adult Stem Cells

  2003cited by this paper
• Immunomodulatory effects of fetal and adult mesenchymal stem cells.

  2003cited by this paper
• Immunomodulatory effects of fetal and adult mesenchymal stem cells.

  2003cited by this paper
• Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation

  2003influential reference
• Immunomodulatory effects of human foetal liver-derived mesenchymal stem cells

  2003cited by this paper
• Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide.

  2003cited by this paper
• Treatment of high‐risk acute myelogenous leukaemia by myeloablative chemoradiotherapy followed by co‐infusion of T cell‐depleted haematopoietic stem cells and culture‐expanded marrow mesenchymal stem cells from a related donor with one fully mismatched human leucocyte antigen haplotype

  2002cited by this paper
• Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34(+) cells in NOD/SCID mice.

  2002cited by this paper
• Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone

  2002cited by this paper
• Isolation and characterization of bone marrow multipotential mesenchymal progenitor cells.

  2002cited by this paper
• bloodjournal.hematologylibrary.org at PENN STATE UNIVERSITY on February 20, 2013. For personal use

  2002cited by this paper
• Treatment of high-risk acute myelogenous leukaemia by myeloablative chemoradiotherapy followed by co-infusion of T cell-depleted haematopoietic stem cells and culture-expanded marrow mesenchymal stem cells from a related donor with one fully mismatched human leucocyte antigen haplotype

  2002cited by this paper

• Bio fluid exosomes: promises, challenges, and future directions in translational medicine

  2025cites this paper
• Adipose-derived mesenchymal stromal/stem cells in type 1 diabetes treatment

  2025cites this paper
• Engineering of a CuO-Releasing 3D-Printed Bilayer Skin Substitute with Improved Angiogenesis: In Vitro and In Vivo Evaluations

  2025cites this paper
• Engineering the Immune Response to Biomaterials

  2025cites this paper
• Navigating the Immunological Crossroads: Mesenchymal Stem/Stromal Cells as Architects of Inflammatory Harmony in Tissue-Engineered Constructs

  2024cites this paper
• Evidence-Based Clinical Practice Guidelines on Regenerative Medicine Treatment for Chronic Pain: A Consensus Report from a Multispecialty Working Group

  2024cites this paper
• Role of miR-21-5p in the protective effects of PLGA-encapsulated extracellular vesicles from urine-derived stem cells on periprosthetic osteolysis

  2024cites this paper
• Current advances in wound healing and regenerative medicine.

  2023cites this paper
• Embryonic-stem-cell-derived mesenchymal stem cells relieve experimental contact urticaria by regulating the functions of mast cells and T cells

  2023cites this paper
• Fabricating the cartilage: recent achievements

  2023cites this paper
• Adipose-derived Mesenchymal Stem Cells Therapy as a new Treatment Option for Diabetes Mellitus

  2023cites this paper
• Cytokine Profile and Anti-Inflammatory Activity of a Standardized Conditioned Medium Obtained by Coculture of Monocytes and Mesenchymal Stromal Cells (PRS CK STORM)

  2022cites this paper
• A multifunctional micropore-forming bioink with enhanced anti-bacterial and anti-inflammatory properties

  2022cites this paper
• Role of biomaterials in the diagnosis, prevention, treatment, and study of corona virus disease 2019 (COVID-19)

  2021cites this paper
• Highlights on Advancing Frontiers in Tissue Engineering

  2021cites this paper
• Therapeutic use of stem cells in Mexico: Status and perspectives

  2021cites this paper
• A Patch of Detachable Hybrid Microneedle Depot for Localized Delivery of Mesenchymal Stem Cells in Regeneration Therapy

  2020cites this paper
• 3D Bioprinting of Oxygenated Cell‐Laden Gelatin Methacryloyl Constructs

  2020cites this paper
• Glutathione-related inflammatory signature in hepatocytes differentiated from the progenitor mesenchymal stem cells☆

  2020cites this paper
• Extracellular Vesicles: The New Frontier of Stem Cell Regenerative Medicine?

  2020cites this paper
• Mesenchymal and Induced Pluripotent Stem Cells-Derived Extracellular Vesicles: The New Frontier for Regenerative Medicine?

  2020cites this paper
• Effect of culture environement on mesenchymal stem cell immunomodulatory ability

  2020influential citation
• Embryonic stem cells as a cell source for tissue engineering

  2020cites this paper
• Clinical Application of Stem/Stromal Cells in Cystic Fibrosis

  2019cites this paper
• Stem Cell-Based Therapy for Lung Disease

  2019cites this paper
• Screen-enrich-combine circulating system to prepare MSC/β-TCP for bone repair in fractures with depressed tibial plateau.

  2019cites this paper
• Mesenchymal stem cell therapy for the treatment of traumatic brain injury: progress and prospects

  2019cites this paper
• Effects of Space Microgravity on the Trans-differentiation Between Osteogenesis and Adipogenesis of Human Marrow-Derived Mesenchymal Stem Cells

  2019cites this paper
• Addressing Stem Cell Therapeutic Approaches in Pathobiology of Diabetes and Its Complications

  2018cites this paper
• Early immune response regulated by a bone marrow mesenchymal stem cell model of multiple trauma in rats.

  2018cites this paper
• Biosafety and bioefficacy assessment of human mesenchymal stem cells: what do we know so far?

  2018cites this paper
• Cell therapy for heart disease after 15 years: Unmet expectations

  2018cites this paper
• Decisional tools for cost-effective bioprocess design for cell therapies and patient-specific drug discovery tools

  2018cites this paper
• Germline cells derived from mesenchymal stem cells, with the focus on Wharton's jelly

  2018cites this paper
• Allogeneic Mesenchymal Stem Cells for Treatment of AKI after Cardiac Surgery.

  2017cites this paper
• Mesenchymal Stem Cells: A Future Option for Intervening Disease Management

  2017cites this paper
• Stem cell-transplantation therapy for adrenoleukodystrophy: current perspectives

  2017cites this paper
• A CLONAL POPULATION OF ALLOGENEIC BONE MARROW FIBROBLASTS INDIRECTLY MITIGATES DAMAGE IN MYOCARDIAL INFARCTION

  2017cites this paper
• Functional genomic fabrics are remodeled in a mouse model of Chagasic cardiomyopathy and restored following cell therapy.

  2017cites this paper
• Protective Effect of Mesenchymal Stem Cells Against the Development of Intracranial Aneurysm Rupture in Mice

  2017cites this paper
• Synovial mesenchymal stem cells from osteo- or rheumatoid arthritis joints exhibit good potential for cartilage repair using a scaffold-free tissue engineering approach.

  2016cites this paper
• Mesenchymal Stem Cell Therapy in Rheumatoid Arthritis

  2016cites this paper
• Stem Cells and Lung Regeneration

  2016cites this paper
• Therapeutic Purposes and Risks of Ex Vivo Expanded Mesenchymal Stem/Stromal Cells

  2016cites this paper
• Heart Regeneration with Embryonic Cardiac Progenitor Cells and Cardiac Tissue Engineering.

  2015cites this paper
• 16S rRNA gene sequencing is a non-culture method of defining the specific bacterial etiology of ventilator-associated pneumonia.

  2015cites this paper
• The effect of mesenchymal stem cells on leukocyte allergen-specific reactions in the case of atopic hypersensitivity

  2015cites this paper
• Graphene oxide: a carrier for pharmaceuticals and a scaffold for cell interactions.

  2015cites this paper
• Stem Cell Aging: Mechanisms, Consequences, Rejuvenation

  2015cites this paper
• The paracrine effect of mesenchymal human stem cells restored hearing in β-tubulin induced autoimmune sensorineural hearing loss.

  2015cites this paper
• Bone marrow-derived mesenchymal stem cell transplantation ameliorates oxidative stress and restores intestinal mucosal permeability in chemically induced colitis in mice.

  2015cites this paper
• Engineering surfaces to control neurogenesis

  2015cites this paper
• Discussion of Animal Stem Cells in the Classroom: Engaging Students through the Lens of Veterinary Medicine

  2015cites this paper
• Mesenchymal Stem Cells in Wound Repair, Tissue Homeostasis, and Aging

  2015cites this paper
• Wharton’s Jelly-Derived Mesenchymal Stromal Cells as a Promising Cellular Therapeutic Strategy for the Management of Graft-versus-Host Disease

  2015cites this paper
• Pharmacokinetics of Natural and Engineered Secreted Factors Delivered by Mesenchymal Stromal Cells

  2014cites this paper
• Supplementing mesenchymal stem cells improves the therapeutic effect of hematopoietic stem cell transplantation in the treatment of murine systemic lupus erythematosus.

  2014cites this paper
• Path to the clinic: assessment of iPSC-based cell therapies in vivo in a nonhuman primate model.

  2014cites this paper
• Long‐term evaluation of mesenchymal stem cell therapy in a feline model of chronic allergic asthma

  2014cites this paper
• Activin B promotes BMSC-mediated cutaneous wound healing by regulating cell migration via the JNK-ERK signaling pathway.

  2014cites this paper
• Activin B Promotes BMSC-Mediated Cutaneous Wound Healing by Regulating Cell Migration via the JNK-ERK Signaling Pathway.

  2014cites this paper
• Trichostatin A Induces Both Cell Division Arrest and Neural-linage Differentiation of the Mesenchymal Stem Cells Possibly by Triggering Wnt/β-Catenin Signaling

  2014cites this paper
• Supplementing Mesenchymal Stem Cells Improves the Therapeutic Effect of Hematopoietic Stem Cell Transplantation in the Treatment of Murine Systemic Lupus Erythematosus

  2014cites this paper
• Tissue Engineering Considerations in Dental Pulp Regeneration

  2013cites this paper
• Immunoregulatory Properties of Mesenchymal Stem Cells: In Vitro and In Vivo

  2013cites this paper
• Repair of meniscal lesions using a scaffold-free tissue-engineered construct derived from allogenic synovial MSCs in a miniature swine model.

  2013cites this paper
• Long-term outcome of the repair of 50 mm long median nerve defects in rhesus monkeys with marrow mesenchymal stem cells-containing, chitosan-based tissue engineered nerve grafts.

  2013cites this paper
• Electroacupuncture Promotes the Differentiation of Transplanted Bone Marrow Mesenchymal Stem Cells Overexpressing TrkC into Neuron-Like Cells in Transected Spinal Cord of Rats

  2013cites this paper
• The potential use of mesenchymal stem cells in hematopoietic stem cell transplantation

  2013cites this paper
• Mesenchymal stem cells for the treatment and prevention of graft-versus-host disease: experiments and practice

  2013cites this paper
• Immunomodulatory Effects of DPSC

  2013cites this paper
• Role of Bone Marrow Derived Mesenchymal Stem Cells in Management of Graft Versus Host Disease

  2013cites this paper
• Recent Patents Pertaining to Immune Modulation and Musculoskeletal Regeneration with Wharton's Jelly Cells.

  2013cites this paper
• Wharton's jelly or bone marrow mesenchymal stromal cells improve cardiac function following myocardial infarction for more than 32 weeks in a rat model: a preliminary report.

  2013cites this paper
• In vitro assessment of mesenchymal stem cells immunosuppressive potential in multiple sclerosis patients.

  2013cites this paper
• Sarcomas as a mise en abyme of mesenchymal stem cells: exploiting interrelationships for cell mediated anticancer therapy.

  2012cites this paper
• Rat Mesenchymal Stromal Cells Inhibit T Cell Proliferation but Not Cytokine Production Through Inducible Nitric Oxide Synthase

  2012cites this paper
• The Role of Mesenchymal Stem Cells in the Tumor Microenvironment

  2012cites this paper
• Differentiating human stem cells into neurons and glial cells for neural repair.

  2012cites this paper
• Molecular targeting regulation of proliferation and differentiation of the bone marrow-derived mesenchymal stem cells or mesenchymal stromal cells.

  2012cites this paper
• Second-harmonic generation microscopy used to evaluate the effect of the dimethyl sulfoxide in the cryopreservation process in collagen fibers of differentiated chondrocytes

  2012cites this paper
• ELISPOT assay as a tool to study the effects of stem cells on cytokine secretion.

  2012cites this paper
• Introduction to Stem Cells and Regenerative Medicine

  2012cites this paper
• Effects of two mesenchymal cell populations on hepatocytes and lymphocytes

  2012cites this paper
• Subpopulation Composition and Activation of T Lymphocytes during Coculturing with Mesenchymal Stromal Cells in Medium with Different O2 Content

  2011cites this paper
• Regeneration of Dental Pulp by Stem Cells

  2011cites this paper
• Immunomodulative Efficacy of Bone Marrow-Derived Mesenchymal Stem Cells Cultured in Human Platelet Lysate

  2011cites this paper
• Mycoplasma Contamination Revisited: Mesenchymal Stromal Cells Harboring Mycoplasma hyorhinis Potently Inhibit Lymphocyte Proliferation In Vitro

  2011cites this paper
• The therapeutic potential of bone marrow‐derived stromal cells

  2011cites this paper
• Functional and Transcriptomic Recovery of Infarcted Mouse Myocardium Treated with Bone Marrow Mononuclear Cells

  2011cites this paper
• Syddansk Universitet Immunogenicity and Immune-Modulating Properties of Human Stem Cells

  2011influential citation
• Immunogenicity and Immune-Modulating Properties of Human Stem Cells

  2011influential citation
• Risk factors in the development of stem cell therapy

  2011influential citation
• Mesenchymal Stromal Cells: An Emerging Cell-Based Pharmaceutical

  2011cites this paper
• Prediction, diagnosis and treatment of experimental graft-versus-host disease : an investigation of genomic, molecular and cellular factors in graft-versus-host disease and mesenchymal stromal cell therapy in a rat model of allogeneic stem cell transplantation

  2011cites this paper
• Promising cellular therapeutics for prevention or management of graft-versus-host disease (a review).

  2011cites this paper
• Administering human adipose-derived mesenchymal stem cells to prevent and treat experimental arthritis.

  2011cites this paper
• Stem cells in clinical practice: applications and warnings

  2011cites this paper
• Bone marrow stromal cells inhibit mast cell function via a COX2‐dependent mechanism

  2011cites this paper
• The therapeutic efficacy of human adipose tissue‐derived mesenchymal stem cells on experimental autoimmune hearing loss in mice

  2011cites this paper